Skip to main content

Table 2 Characteristics of the participants in the second screening step (n = 1,712) by sex including Finnish Diabetes Risk Score (FINDRISC), glucose and hemoglobin (Hb)A1c findings

From: Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy

Parameter

Overall

Male

Female

p

Number of participants (n)

1712

569 (33.2)

1143 (66.8)

-

Age, years

60.7 ± 8.2

62.4 ± 8.1

59.8 ± 8.1

<0.01

   45 to 54

464 (27.1)

124 (21.8)

340 (29.7)

 

   55 to 64

640 (37.4)

187 (32.9)

453 (39.6)

 

   >65

608 (35.5)

258 (45.3)

350 (30.6)

 

BMI, kg/m2

29.7 ± 4.7

29.5 ± 3.9

29.7 ± 5.1

0.43

   <25

240 (14.0)

59 (10.4)

181 (15.8)

 

   25 to 30

740 (43.2)

274 (48.2)

466 (40.8)

 

   ≥30

732 (42.8)

236 (41.5)

496 (43.4)

 

Waist circumference, cm

97.4 ± 11.5

102.0 ± 9.8

95.2 ± 11.6

<0.01

   M <94, F <80

193 (11.3)

87 (15.3)

106 (9.3)

 

   M 94 to 102, F 80 to 88

463 (27.0)

205 (36.0)

258 (22.6)

 

   M ≥103, F ≥89

1056 (61.7)

277 (48.7)

779 (68.2)

 

Systolic blood pressure, mmHg

132.6 ± 15.5

135.0 ± 14.8

131.5 ± 15.7

<0.01

Diastolic blood pressure, mmHg

78.8 ± 11.4

79.2 ± 9.4

78.6 ± 12.4

0.33

FINDRISC, items

13.5 ± 4.4

13.2 ± 4.2

13.7 ± 4.5

0.04

   Low risk (<7)

98 (5.7)

29 (5.1)

69 (6.0)

 

   Slightly increased risk (7 to 11)

475 (27.7)

174 (30.6)

301 (26.3)

 

   Moderate risk (12 to 14)

416 (24.3)

135 (23.7)

281 (24.6)

 

   High risk (15 to 20)

633 (37.0)

212 (37.3)

421 (36.8)

 

   Very high risk (>20)

90 (5.3)

19 (3.3)

71 (6.2)

 

2-hour Plasma glucose, mmol/l

6.8 ± 2.8

7.4 ± 3.0

6.6 ± 2.7

<0.01

   Diabetes

158 (9.2)

70 (12.3)

88 (7.7)

 

   Pre-diabetes

380 (22.2)

167 (29.3)

213 (18.6)

 

Fasting plasma glucose, mmol/l

5.2 ± 1.0

5.4 ± 1.1

5.1 ± 1.0

<0.01

   Diabetes

53 (3.1)

22 (3.9)

31 (2.7)

 

   Pre-diabetes

432 (25.2)

189 (33.2)

243 (21.3)

 

HbA1c (NGSP),%b

5.5 ± 0.6

5.5 ± 0.6

5.5 ± 0.6

0.26

HbA1c (IFCC), mmol/mol

36.3 ± 6.4

36.6 ± 6.7

36.2 ± 6.3

0.26

   Diabetes

62 (3.6)

23 (4.0)

39 (3.4)

 

   Pre-diabetes

429 (25.1)

149 (26.2)

280 (24.5)

 
  1. aData are means ± SE for quantitative variables or n (%) for qualitative variables.
  2. bHbA1c values have been indicated in accordance with both the National Glycohemoglobin Standardization Program (NGSP) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) criteria.